Exegiline Pharma Overview
Exegiline Pharma is developing a novel multifunctional oral drug, MT-031, for the treatment of dementia and Alzheimer's disease. MT-031's structure combines rivastigmine (Exelon) and rasagiline (Azilect) moieties and has the beneficial properties of both and more. It works as a dual acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitor as well a selective irreversible inhibition of MAO-A. MT-031 has a brain-permeable novel multifunctional MAO-AChE/BuChe inhibitor, anti-inflammatory properties, neuroprotective activity, and cognitive- and memory-enhancing activities. The molecule and its indications are protected by US and European patents. The company was established at Youdim Pharmaceuticals, a pharmaceutical company and incubator.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
Locations
Ha-Tsmikha Street 1, Yokne'am Illit, Israel
Photos & Videos
No files yet
Exegiline Pharma Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsMoleculesTags (10)
drug-developmentparkinsonoral-drugspharma-companiesneurologybrain-disordertreatmentsdegenerative-diseasespharmaceuticalsalzheimers-diseaseExegiline Pharma Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Exegiline Pharma Lifecycle
Cumulative Funding Raised Over Time
All Events
Exegiline Pharma News
1 articleExegiline Pharma Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Exegiline Pharma Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 84/100 |
| Missing | homepage, video or image, markets, external profiles, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 516301991 |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-09-22T00:00:00.000Z |
| Created | 2021-02-22T00:00:00.000Z |